drugset / Trial / NCT03878693

4-methylpyrazole and Acetaminophen Metabolism

NCT03878693 ↗

Phase 0 Completed 6 enrolled University of Arizona
RandomizedSingle-groupOpen-labelOther

Summary

Oxidative metabolism of APAP will be studied with and without 4-MP.

Timeline

Start
2018-07-01
Primary completion
2018-10-31
Completion
2018-10-31

Outcome

Met primary endpoint

paper Compared with APAP alone, co-treatment with 4-MP decreased the percentage of ingested APAP recovered as oxidative metabolites in 24-hour urine from 4.48 to 0.51% PMID 31768936 ↗

paper from 4.48 to 0.51% (95% CI = 2.31-5.63%, p = 0.003). PMID 31768936 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 80 mg/kg Oral
Subject Fomepizole Unknown — Intravenous

Indications

No indication recorded.